Get the Stockscreener App
32.20
4.04%
1.25
After Hours:
32.02
-0.18
-0.56%
Tg Therapeutics Inc stock is traded at $32.20, with a volume of 2.58M.
It is up +4.04% in the last 24 hours and up +3.37% over the past month.
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). and the company is developing TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders which are under Phase 1 trial.
See More
Previous Close:
$30.95
Open:
$30.6
24h Volume:
2.58M
Relative Volume:
0.78
Market Cap:
$5.01B
Revenue:
$264.79M
Net Income/Loss:
$-14.36M
P/E Ratio:
-115.00
EPS:
-0.28
Net Cash Flow:
$-28.11M
1W Performance:
+0.56%
1M Performance:
+3.37%
6M Performance:
+89.63%
1Y Performance:
+87.10%
1-Day Range:
$30.50
$32.62
1-Week Range:
$30.41
$35.03
52-Week Range:
$12.84
$36.84
Tg Therapeutics Inc Stock (TGTX) Company Profile
Name
Tg Therapeutics Inc
Sector
Industry
Phone
(212) 554-4484
Address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
32.20 | 5.01B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-24 | Initiated | TD Cowen | Buy |
| Aug-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-26-23 | Resumed | Jefferies | Buy |
| May-20-22 | Initiated | BofA Securities | Underperform |
| Feb-23-22 | Reiterated | B. Riley Securities | Buy |
| Nov-15-21 | Downgrade | Goldman | Neutral → Sell |
| Apr-20-21 | Initiated | Goldman | Neutral |
| Apr-19-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-01-20 | Initiated | JP Morgan | Overweight |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-05-20 | Initiated | Evercore ISI | Outperform |
| Jan-17-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-27-19 | Resumed | B. Riley FBR | Buy |
| Feb-06-19 | Resumed | Jefferies | Buy |
| Sep-25-18 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-09-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Dec-01-17 | Resumed | B. Riley FBR, Inc. | Buy |
| Nov-14-17 | Resumed | H.C. Wainwright | Buy |
| Apr-25-17 | Initiated | Jefferies | Buy |
| Mar-06-17 | Reiterated | FBR & Co. | Outperform |
| Oct-06-16 | Resumed | Brean Capital | Buy |
| May-27-16 | Initiated | SunTrust | Buy |
| Dec-01-15 | Initiated | FBR Capital | Outperform |
| Sep-09-15 | Initiated | Raymond James | Strong Buy |
| Aug-12-15 | Resumed | H.C. Wainwright | Buy |
| Jun-19-15 | Reiterated | Brean Capital | Buy |
| Dec-11-14 | Reiterated | ROTH Capital | Buy |
| Dec-10-14 | Reiterated | ROTH Capital | Buy |
View All
Tg Therapeutics Inc Stock (TGTX) Latest News
Synovus Financial Corp Makes New Investment in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Teachers Retirement System of The State of Kentucky Makes New $1.04 Million Investment in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Holdings Lifted by Barclays PLC - MarketBeat
(TGTX) Long Term Investment Analysis - Stock Traders Daily
High Growth Tech Stocks To Watch In The United States - Simply Wall St
Exome Asset Management LLC Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Stock Rating Upgraded by StockNews.com - MarketBeat
Interesting TGTX Put And Call Options For January 2025 - Nasdaq
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Purchased by State Street Corp - MarketBeat
Neo Ivy Capital Management Acquires Shares of 100,780 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 27,947 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by Fmr LLC - MarketBeat
168,810 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Purchased by Castleark Management LLC - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Rating Lowered to "Sell" at StockNews.com - MarketBeat
(TGTX) Trading Report - Stock Traders Daily
Waldenstrom Macroglobulinemia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | AbbVie, Cellectar Biosciences, TG Therapeutics, Eli Lilly and Company, Celgene Corp - Barchart
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by BNP Paribas Financial Markets - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
Citigroup Inc. Has $3.94 Million Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics (NASDAQ:TGTX) shareholders have earned a 30% CAGR over the last five years - Simply Wall St
This Is What Whales Are Betting On TG Therapeutics - Benzinga
TG Therapeutics to Participate in the Evercore HealthCONx Conference - Marketscreener.com
PDT Partners LLC Buys New Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Public Sector Pension Investment Board Invests $6.62 Million in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics CEO to Present at Evercore HealthCONx Conference | TGTX Stock News - StockTitan
Thrivent Financial for Lutherans Acquires New Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Mutual of America Capital Management LLC Invests $469,000 in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Intech Investment Management LLC Takes $1.13 Million Position in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Algert Global LLC Trims Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics price target raised to $43 from $30 at JPMorgan - Yahoo Finance
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought by Penserra Capital Management LLC - MarketBeat
(TGTX) Investment Analysis - Stock Traders Daily
TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - Benzinga
TG Therapeutics (NASDAQ:TGTX) Sets New 1-Year High Following Analyst Upgrade - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $43.00 - MarketBeat
Eagle Asset Management Inc. Makes New $3.95 Million Investment in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
52,390 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Purchased by Segall Bryant & Hamill LLC - MarketBeat
NYC biotech venture tops Deloitte's Technology Fast 500 - The Business Journals
TG Therapeutics Stock Soars Nearly 15% After Topping Deloitte's Fast 500 and Raising Revenue Outlook - GuruFocus.com
A Closer Look at TG Therapeutics's Options Market Dynamics - Benzinga
Deloitte Unveils 2024 North America Technology Fast 500™ Rankings - The Malaysian Reserve
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - The Manila Times
TG Therapeutics Claims #1 Spot on Deloitte Fast 500 List, Driven by MS Drug Success | TGTX Stock News - StockTitan
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte - The Bakersfield Californian
TG Therapeutics Ranked Number One Fastest-Growing Company - GlobeNewswire
Oppenheimer & Co. Inc. Invests $759,000 in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
When (TGTX) Moves Investors should Listen - Stock Traders Daily
Entropy Technologies LP Purchases Shares of 31,200 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Principal Financial Group Inc. Raises Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Tg Therapeutics Inc Stock (TGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tg Therapeutics Inc Stock (TGTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Charney Laurence N | Director |
Nov 11 '24 |
Sale |
30.20 |
25,000 |
754,875 |
212,479 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):